Abstract
Purpose
Papillary thyroid cancer (PTC) has good prognosis with a very low chance of mortality. The prognostic role of metastatic lymph node location was judged controversial and more recently (TNM VIII ed.) was considered to have no impact on the prognosis of older patients. The aim of the study was to evaluate the role of metastasized node location on PTC-related mortality.
Methods
PTC-related mortality was analysed in a consecutive retrospective series of 1653 PTC patients followed at our Thyroid Clinic (mean follow-up 5.9 years).
Results
Sixteen out of 1653 patients (0.96%) died because of PTC. Average age was 68 years at presentation and 74.7 at death. F/M ratio was 1:1. The death rate increased in relation to the lymph node status: 0.2% in N0, 0.3% in N1a and 3.0% in N1b.
Conclusions
The presence of lymph node metastases in the N1b compartment should be considered as a risk factor for distant metastatic spread and for cancer-related death and included in post-surgery evaluation.
References
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf. Accessed 20 Dec 2017
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid Off J Am Thyroid Assoc 26(1):1–133. https://doi.org/10.1089/thy.2015.0020
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348. https://doi.org/10.1001/jama.2017.2719
Sapuppo G, Palermo F, Russo M, Tavarelli M, Masucci R, Squatrito S, Vigneri R, Pellegriti G (2017) Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome. J Endocrinol Invest 40(12):1355–1363. https://doi.org/10.1007/s40618-017-0714-y
Pacini F, Brianzoni E, Durante C, Elisei R, Ferdeghini M, Fugazzola L, Mariotti S, Pellegriti G (2016) Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology. J Endocrinol Invest 39(3):341–347. https://doi.org/10.1007/s40618-015-0375-7
Kim M, Kim WG, Oh HS, Park S, Kwon H, Song DE, Kim TY, Shong YK, Kim WB, Sung TY, Jeon MJ (2017) Comparison of the seventh and eighth editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-node-metastasis staging system for differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc 27(9):1149–1155. https://doi.org/10.1089/thy.2017.0050
Steinschneider M, Muallem Kalmovich L, Koren S, Or K, Cantrell D, Benbassat C (2017) Reassessment of differentiated thyroid cancer patients using the 8th TNM classification system: a comparative study. Thyroid Off J Am Thyroid Assoc. https://doi.org/10.1089/thy.2017.0265
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have nothing to declare.
Ethical approval
All procedures involving human participants were in accordance with the ethical standards of institutional research committee, with the Helsinki declaration and its later amendments.
Informed consent
Informed consent of the present retrospective study was waived.
Rights and permissions
About this article
Cite this article
Sapuppo, G., Tavarelli, M., Russo, M. et al. Lymph node location is a risk factor for papillary thyroid cancer-related death. J Endocrinol Invest 41, 1349–1353 (2018). https://doi.org/10.1007/s40618-018-0865-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0865-5